Fitxa persona

He completed his doctoral studies at the Universitat de València (UV) and the Centro de Investigación Príncipe Felipe in 2014, with a thesis dedicated to the study of the function of the protein kinase Goodpasture antigen-binding protein (GPBP), and its effector, GPBP-interacting protein (GIP), in skeletal muscle. Following his Ph.D., he continued his research career at a UV spin-off company, investigating the mechanism of action of GPBP inhibitors/blockers. His participation in the projects at this spin-off allowed him to apply his prior experience in molecular and cellular biology techniques to in vitro and ex vivo assays, as well as in vivo studies using genetically modified murine models. This work, which had a more translational research focus, contributed to the development of patents, scientific publications, and conference presentations.

To further enhance his expertise, he recently pursued a Master's degree in Bioinformatics at the University of Valencia, which he completed in 2021. This program provided him with knowledge in programming and biostatistics. Currently, he is part of the Mixed Unit of Research in Experimental Hepatology (IIS La Fe - UV), where he participates in constructing and analyzing clinical databases related to drug-induced liver toxicity for a European project (ONTOX: “Ontology-driven and artificial intelligence-based repeated dose toxicity testing of chemicals for next generation risk assessment”) supported by artificial intelligence technology.